Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it
will present at the Barclays Global Healthcare Conference on Tuesday,
March 11 at 8:00 a.m. ET.
The audio portion of the remarks will be accessible live through
Vertex's website at www.vrtx.com>
in the "Investors" section under the "Events and Presentations" link. To
ensure a timely connection, it is recommended that users register at
least 15 minutes prior to the scheduled webcast. A replay of the webcast
will also be archived on the company's website for a period of two weeks
following the presentation.
Vertex is a global biotechnology company that aims to discover, develop
and commercialize innovative medicines so people with serious diseases
can lead better lives. Vertex scientists and our collaborators are
working on new medicines to cure or significantly advance the treatment
of cystic fibrosis, hepatitis C, rheumatoid arthritis and other
life-threatening diseases. In addition to our clinical development
programs, Vertex has more than a dozen ongoing preclinical programs
aimed at other serious and life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and
development sites and commercial offices in the United States, Europe,
Canada and Australia. For four years in a row, Science magazine has
named Vertex one of its Top Employers in the life sciences. For
additional information and the latest updates from the company, please
[ Back To NFVZone's Homepage ]